Role of the glucagon-like-peptide-1 receptor in the control of energy balance

被引:147
作者
Hayes, Matthew R. [1 ]
De Jonghe, Bart C. [2 ]
Kanoski, Scott E. [1 ]
机构
[1] Univ Penn, Dept Psychol, Sch Arts & Sci, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Anim Biol, Sch Vet Med, Philadelphia, PA 19104 USA
关键词
GLUCAGON-LIKE PEPTIDE-1; Y GASTRIC BYPASS; ACTIVATED PROTEIN-KINASE; DEPENDENT INSULINOTROPIC POLYPEPTIDE; CARDIOVASCULAR RISK-FACTORS; NUCLEUS-TRACTUS-SOLITARIUS; REGULATE FOOD-INTAKE; CAUDAL BRAIN-STEM; GLUCOSE-TOLERANCE; BODY-WEIGHT;
D O I
10.1016/j.physbeh.2010.02.029
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
The peripheral and central glucagon-like-peptide-1 (GLP-1) systems play an essential role in glycemic and energy balance regulation. Thus, pharmacological targeting of peripheral and/or central GLP-1 receptors (GLP-1R) may represent a potential long-term treatment option for both obesity and type-II diabetes mellitus (T2DM). Uncovering and understanding the neural pathways, physiological mechanisms, specific GLP-1R populations, and intracellular signaling cascades that mediate the food intake inhibitory and incretin effects produced by GLP-1R activation are vital to the development of these potential successful therapeutics. Particular focus will be given to the essential role of the nucleus tractus solitarius (NTS) in the caudal brainstem, as well as the gut-to-brain communication by vagal afferent fibers in mediating the physiological and behavioral responses following GLP-1R activation. The paper represents an invited review by a symposium, award winner or keynote speaker at the Society for the Study of Ingestive Behavior [SSIB] Annual Meeting in Portland, July 2009. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:503 / 510
页数:8
相关论文
共 126 条
  • [1] The inhibitory effects of peripheral administration of peptide YY3-36 and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway
    Abbott, CR
    Monteiro, M
    Small, CJ
    Sajedi, A
    Smith, KL
    Parkinson, JRC
    Ghatei, MA
    Bloom, SR
    [J]. BRAIN RESEARCH, 2005, 1044 (01) : 127 - 131
  • [2] Sensory nerves contribute to insulin secretion by glucagon-like peptide-1 in mice
    Ahrén, B
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2004, 286 (02) : R269 - R272
  • [3] Portal GLP-1 administration in rats augments the insulin response to glucose via neuronal mechanisms
    Balkan, B
    Li, X
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2000, 279 (04) : R1449 - R1454
  • [4] BARABOI ED, 2010, AM J PHYSL REGUL INT
  • [5] Interactions of exendin-(9-39) with the effects of glucagon-like peptide-1-(7-36) amide and of exendin-4 on arterial blood pressure and heart rate in rats
    Barragan, JM
    Rodriguez, RE
    Eng, J
    Blazquez, E
    [J]. REGULATORY PEPTIDES, 1996, 67 (01) : 63 - 68
  • [6] Neural contribution to the effect of glucagon-like peptide-1-(7-36) amide on arterial blood pressure in rats
    Barragán, JM
    Eng, J
    Rodríguez, R
    Blázquez, E
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1999, 277 (05): : E784 - E791
  • [7] Brain-adipose tissue neural crosstalk
    Bartness, Timothy J.
    Song, C. Kay
    [J]. PHYSIOLOGY & BEHAVIOR, 2007, 91 (04) : 343 - 351
  • [8] The brain, appetite, and obesity
    Berthoud, Hans-Rudolf
    Morrison, Christopher
    [J]. ANNUAL REVIEW OF PSYCHOLOGY, 2008, 59 : 55 - 92
  • [9] Multiple neural systems controlling food intake and body weight
    Berthoud, HR
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2002, 26 (04) : 393 - 428
  • [10] Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes
    Blonde, L.
    Klein, E. J.
    Han, J.
    Zhang, B.
    Mac, S. M.
    Poon, T. H.
    Taylor, K. L.
    Trautmann, M. E.
    Kim, D. D.
    Kendall, D. M.
    [J]. DIABETES OBESITY & METABOLISM, 2006, 8 (04) : 436 - 447